These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8476199)
1. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. De Loecker W; Janssens J; Bonte J; Taper HS Anticancer Res; 1993; 13(1):103-6. PubMed ID: 8476199 [TBL] [Abstract][Full Text] [Related]
3. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Noto V; Taper HS; Jiang YH; Janssens J; Bonte J; De Loecker W Cancer; 1989 Mar; 63(5):901-6. PubMed ID: 2914296 [TBL] [Abstract][Full Text] [Related]
4. The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma. von Gruenigen VE; Jamison JM; Gilloteaux J; Lorimer HE; Summers M; Pollard RR; Gwin CA; Summers JL Anticancer Res; 2003; 23(4):3279-87. PubMed ID: 12926064 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis-inducing activity of vitamin C and vitamin K. Sakagami H; Satoh K; Hakeda Y; Kumegawa M Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):129-43. PubMed ID: 10726979 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of the antiproliferative effect of vitamin K3 on Jurkat cells. Kovalenko DV; Zelenin AV Biochemistry (Mosc); 1999 Apr; 64(4):468-72. PubMed ID: 10231603 [TBL] [Abstract][Full Text] [Related]
7. [Synergistic effects of tumor necrosis factor interferon-gamma and chemotherapeutic drugs on human ovarian cancer cell lines in vitro]. Li J; Hui N; Zhu L Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):429-31. PubMed ID: 8697994 [TBL] [Abstract][Full Text] [Related]
8. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model. Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538 [TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines. Venugopal M; Jamison JM; Gilloteaux J; Koch JA; Summers M; Hoke J; Sowick C; Summers JL Cell Biol Int; 1996 Dec; 20(12):787-97. PubMed ID: 9032939 [TBL] [Abstract][Full Text] [Related]
10. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Chlebowski RT; Dietrich M; Akman S; Block JB Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875 [TBL] [Abstract][Full Text] [Related]
11. A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer. Dai D; Holmes AM; Nguyen T; Davies S; Theele DP; Verschraegen C; Leslie KK Cancer Res; 2005 Oct; 65(20):9517-24. PubMed ID: 16230417 [TBL] [Abstract][Full Text] [Related]
12. Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin. Taper HS; Roberfroid M Anticancer Res; 1992; 12(5):1651-4. PubMed ID: 1444232 [TBL] [Abstract][Full Text] [Related]
13. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
14. Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells. Liao WC; Wu FY; Wu CW Int J Oncol; 2000 Aug; 17(2):323-8. PubMed ID: 10891542 [TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis. Menon M; Maramag C; Malhotra RK; Seethalakshmi L Cancer Biochem Biophys; 1998 Jun; 16(1-2):17-30. PubMed ID: 9923964 [TBL] [Abstract][Full Text] [Related]
16. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Foroodi F; Duivenvoorden WC; Singh G Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028 [TBL] [Abstract][Full Text] [Related]
17. Combination effect of lignin F and natural products. Jiang Y; Satoh K; Aratsu C; Kobayashi N; Unten S; Kakuta H; Kikuchi H; Nishikawa H; Ochiai K; Sakagami H Anticancer Res; 2001; 21(2A):965-70. PubMed ID: 11396189 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Wu XX; Ogawa O; Kakehi Y Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592 [TBL] [Abstract][Full Text] [Related]
19. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins. Osada S; Osada K; Carr BI J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995 [TBL] [Abstract][Full Text] [Related]
20. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines. Wigington DP; Urben CM; Strugnell SA; Knutson JC Anticancer Res; 2004; 24(5A):2905-12. PubMed ID: 15517895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]